Clinical trial
Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD)…
NCT00222079 · Douglas Trask, Other · Terminated
Key facts
| NCT number | NCT00222079 |
|---|---|
| Title | Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy |
| Official title | Pilot Study to Evaluate Esomeprazole (Nexium) in Treating Gastro-esophageal Reflux in Patients With Head and Neck Cancer With Prior External Beam Radiation Therapy: a Randomized, Prospective, Placebo-controlled, Double-blind Study. |
| Lead sponsor | Douglas Trask, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Gastro-esophageal Reflux |
| Intervention type | Drug |
| Interventions | Esomeprazole (Nexium) |
| Enrollment | 40 |
| Start date | Nov 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: